U.S. Securities and Exchange Commission
                             Washington, D.C. 20549

                                   FORM 10-QSB

[X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
            1934 for the quarterly period ended September 30, 2000.

[ ]      TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934 for the transition period from _______ to
-------

COMMISSION FILE NUMBER 001-06-560
                       ----------

                       FAIRCHILD INTERNATIONAL CORPORATION
                 (Name of Small Business Issuer in its Charter)

           Nevada                                         91-1880015
(State or other jurisdiction of             (IRS Employer Identification Number)
  Incorporation or Organization)

          Suite 600, 596 Hornby Street, Vancouver, B.C. Canada V6C 1A4
           (Address of Principal Executive Offices)         (Zip Code)

                                 (604) 646-5614
                           (Issuer's Telephone Number)


Check whether the issuer (1)filed all reports required to be filed by Section 13
or 15(d) of the  Exchange  Act during  the past 12 months  (or for such  shorter
period that the registrant was required to file such reports),  and (2) has been
subject to such filing requirements for the past 90 days. Yes [X] No [ ]

The number of shares of common stock  outstanding  as of  September  30, 2000 is
10,988,210.

PART 1-FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS



                       FAIRCHILD INTERNATIONAL CORPORATION
                          (A DEVELOPMENT STAGE COMPANY)

                                  BALANCE SHEET

                               SEPTEMBER 30, 2000

                           (EXPRESSED IN U.S. DOLLARS)

                                                                    2000
ASSETS

    CURRENT
       CASH                                                   $            2,814
                                                               =================

LIABILITIES

    CURRENT
       ACCOUNTS PAYABLE                                       $           10,719
       OWING TO RELATED PARTIES                                           67,793
                                                               -----------------

                                                                          78,512
                                                               =================
        COMMITMENTS (NOTE 4)

STOCKHOLDERS' EQUITY (DEFICIENCY)

  SHARE CAPITAL
     AUTHORIZED
     50,000,000  COMMON SHARES WITH A PAR VALUE
                        OF $0.001 PER SHARE
      1,000,000   PREFERRED SHARES WITHOUT PAR VALUE
                        OF $0.01 PER SHARE
ISSUED AND PAID (NOTE 3)
10,988,210 COMMON SHARES                                                 894,769

DEFICIT ACCUMULATED DURING THE
  DEVELOPMENT STAGE                                                    (970,467)
                                                               -----------------

TOTAL STOCKHOLDERS' EQUITY (DEFICIENCY)                                 (75,698)
                                                               -----------------

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY                    $            2,814
                                                               =================

APPROVED BY THE DIRECTOR


                                    UNAUDITED



<TABLE>
<CAPTION>

                       FAIRCHILD INTERNATIONAL CORPORATION
                          (A DEVELOPMENT STAGE COMPANY)

                       STATEMENT OF OPERATIONS AND DEFICIT

              FOR THE NINE MONTHS ENDED SEPTEMBER 30. 2000 AND 1999

                           (EXPRESSED IN U.S. DOLLARS)


                                                      CUMULATIVE                                     PERIODS
                                                          TO                                          ENDED
                                                    SEPTEMBER 30,                    SEPTEMBER 30,              SEPTEMBER 30,
                                                        2000                             2000                     1999
<S>                                                   <C>                              <C>                         <C>
ADMINISTRATIVE EXPENSES

ADVERTISING                                       $            9,008           $       -              $        -
BANK CHARGES AND EXCHANGE                                     12,535                        470                    2,310
CONSULTING                                                    39,267                   -                          25,664
OFFICE, RENT AND SECRETARIAL                                  28,769                      9,613                   12,044
PROFESSIONAL FEES                                             83,750                      7,295                   32,954
PROMOTION AND TRAVEL                                         331,040                      6,000                   97,396
RELATED PARTY
  ADMINISTRATION CHARGES                                     121,855                     12,733                   42,692
  CONSULTING FEES                                             50,000                   -                       -
RESEARCH AND DEVELOPMENT AND
  LICENSE FEES                                               163,520                      5,020                   96,500
SHAREHOLDER INFORMATION                                       19,899                      1,877                    4,099
STOCK OPTION COMPENSATION                                   -                          -                         120,000
TELEPHONE AND UTILITIES                                        3,440                        246                    1,655
TRANSFER AGENT FEES                                            7,757                   -                           3,408
                                                     ----------------            ---------------        -----------------

                                                             870,840                     43,254                  438,722

MINERAL INTERESTS AND
  EXPLORATION COSTS                                           99,627                   -                       -
                                                     ----------------            ---------------        -----------------


NET LOSS FOR THE PERIOD                           $          970,467                     43,254                  438,722
                                                     ================

DEFICIT BEGINNING OF THE PERIOD                                                         927,213                  456,276
                                                                                 ---------------        -----------------

DEFICIT END OF THE PERIOD                                                              $970,467                 $894,998
                                                                                 ===============        =================

BASIC LOSS PER SHARE                                                                      $0.01                    $0.07
                                                                                 ===============        =================

                                                       UNAUDITED
</TABLE>




<TABLE>
<CAPTION>

                       FAIRCHILD INTERNATIONAL CORPORATION
                          (A DEVELOPMENT STAGE COMPANY)

                             STATEMENTS OF CASH FLOW

              FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2000 AND 1999

                           (EXPRESSED IN U.S. DOLLARS)

                                                          CUMULATIVE                                    PERIODS
                                                              TO                                         ENDED
                                                         SEPTEMBER 30,                 SEPTEMBER 30,             SEPTEMBER 30,
                                                            2000                           2000                     1999
<S>                                                     <C>                               <C>                         <C>
CASH PROVIDED (USED) BY
    OPERATING ACTIVITIES

      NET LOSS FOR THE PERIOD                      $        (970,467)          $        (43,254)      $         (438,722)
      NON-CASH ITEMS
          ISSUE OF SHARES FOR SERVICES
           AANDMMINERALIINTEREST                             236,858                   -                          25,000
      CHANGE IN NON-CASH OPERATING ITEM
           STOCK OPTION COMPENSATION                        -                          -                         120,000
           ACCOUNTS PAYABLE                                   10,719                      2,514                    5,876
                                                     ----------------            ---------------        -----------------

                                                            (722,890)                   (40,740)                (287,846)
                                                     ----------------            ---------------        -----------------

FINANCING ACTIVITIES

      OWING TO RELATED PARTIES                                67,793                      6,588                   10,432
      SHARE CAPITAL ISSUED FOR CASH                          657,911                   -                         450,000
                                                     ----------------            ---------------        -----------------

                                                             725,704                      6,588                  460,432
                                                     ----------------            ---------------        -----------------

CHANGE IN CASH FOR THE PERIOD                               -                           (34,152)                 172,586

CASH BEGINNING OF THE PERIOD                                -                            36,966                      595
                                                     ----------------            ---------------        -----------------

CASH END OF THE PERIOD                            $            2,814           $          2,814       $          173,181
                                                     ================            ===============        =================

</TABLE>

                                    UNAUDITED



                       FAIRCHILD INTERNATIONAL CORPORATION
                          (A DEVELOPMENT STAGE COMPANY)

                        NOTES TO THE FINANCIAL STATEMENTS

                               SEPTEMBER 30, 2000


1.                ACCOUNTING POLICIES AND NOTES

         The  accounting  policies  followed by the Company are  unchanged  from
         those outlined in the audited  financial  statements for the year ended
         December 31, 1999.  The notes to the  financial  statements at December
         31, 1999  substantially  apply to the interim  financial  statements at
         September 30, 2000 and are not repeated here. All adjustments have been
         made which,  in the opinion of  management,  are  necessary in order to
         make these financial statements not misleading.

2.                GOING CONCERN CONSIDERATIONS

         As of  September  30,  2000,  the  Company  had not  reached a level of
         operations  which would finance day to day activities.  These financial
         statements  have been prepared on the assumption  that the company is a
         going   concern,   meaning  it  will  continue  in  operation  for  the
         foreseeable  future  and will be able to realize  assets and  discharge
         liabilities in the ordinary  course of operations.  Different  basis of
         measurement  may be  appropriate  when a  company  is not  expected  to
         continue   operations  for  the  foreseeable   future.   The  Company's
         continuation as a going concern is dependent upon its ability to attain
         profitable  operations and generate funds therefrom and/or raise equity
         capital or borrowings from third parties and related parties sufficient
         to meet current and future  obligations.  The Company  suffered  losses
         from  operations  of $43,254 and  $438,722  for the nine  months  ended
         September  30,  2000  and  1999  respectively  and  had a  net  capital
         deficiency of $75,698 as of September 30,2000.


3.                SHARE CAPITAL
                                                      Shares       Consideration
         Common shares issued and fully paid
             Balance at September 30, 2000 and
                  December 31, 1999                  10,988,210       $  894,769
                                                     ----------     ------------


4.                COMMITMENTS

a.       Pharmaceutical Research and Development

         The  Company  has  entered  into  Research,   Development  and  License
         Agreements  to  acquire  an  exclusive  license  to make,  use and sell
         pharmaceutical  products and processes relating to arthritis and dermal
         wrinkles.  The  Company  has  issued  2,600,000  common  shares  and is
         committed  to  funding  $250,000   ($137,520  paid)  for  research  and
         development as consideration  for license.  The shares have been issued
         at a  nominal  value of $.01 per share and are  subject  to  regulatory
         restrictions  relating to their  saleability.  A net revenue royalty of
         35% will be payable by the  Company on revenue for  licensed  products.
         The agreement is with a company formerly under common management.


         The balance of the funding of $112,480 is unpaid and  unaccrued  as the
         registration of certain patents has been delayed.  No notice of default
         under the terms of the agreement has been received.


<PAGE>


                                    UNAUDITED
                                    UNAUDITED


<PAGE>



                       FAIRCHILD INTERNATIONAL CORPORATION
                          (A DEVELOPMENT STAGE COMPANY)

                        NOTES TO THE FINANCIAL STATEMENTS

                               SEPTEMBER 30, 2000

b.       Consulting Agreement

         The Company  has  entered  into a  consulting  agreement  with a former
         director for public relations services and granted an option to acquire
         up to 5% of the  outstanding  common shares of the Company.  The option
         can be exercised when the Company's shares qualify for the NASDAQ small
         cap over the counter  public trading at a price of $.50 per share for a
         period of two years from the date of the listing.


         The exercise price of stock options granted  exceeded the quoted market
         value of the shares. Accordingly, no stock option compensation has been
         recognized in the financial statements






ITEM 2.PLAN OF OPERATION

With the exception of historical facts stated herein,  the matters  discussed in
this  report  are  "forward   looking"   statements   that  involve   risks  and
uncertainties  that  could  cause  actual  results  to  differ  materially  from
projected  results.  Such  "forward  looking"  statements  include,  but are not
necessarily  limited  to,  statements  regarding  anticipated  levels  of future
revenues and earnings from operations of the Company. Readers of this report are
cautioned not to put undue reliance on "forward  looking"  statements which are,
by their nature,  uncertain as reliable  indicators of future  performance.  The
Company  disclaims any intent or obligation  to publicly  update these  "forward
looking" statements,  whether as a result of new information,  future events, or
otherwise.

THE FOLLOWING  DISCUSSION AND ANALYSIS  SHOULD BE READ IN  CONJUNCTION  WITH THE
FINANCIAL STATEMENTS APPEARING ELSEWHERE IN THIS REGISTRATION STATEMENT.

We eventually plan to develop specialized e-commerce sites on the Internet. Over
the next twelve months,  we plan to focus on  development of an Internet  portal
for  alternative  health  care  products.  We hope that this site will offer our
products,  as well as those of other  companies.  In addition,  we plan to offer
information on related topics on the website.

In the past,  we have relied upon funding from our former  officer and director,
Mr.  Stadnyk.  We borrowed  approximately  $44,000 from Mr.  Stadnyk  during our
development stage,  $40,000 of which has been repaid. We are currently unable to
satisfy our cash  requirements  without the financial  support of our President,
Byron  Cox,  or  his  designee.  We  anticipate  that  we  will  meet  our  cash
requirements  for the next twelve months  through Mr. Cox's  financial  support,
even  though  Mr.  Cox  has not  supplied  funds  to the  Company  in the  past.
Currently,  we have no commitment for funding from our past or present  officers
and directors or any other party.  Eventually,  we will need to raise additional
funds,  if we plan to implement an advertising and marketing plan to advance our
website.  We have not yet  determined  how we plan to  obtain  these  additional
funds.

In 1999,  we raised cash  proceeds of $475,000 from the sale of our common stock
to business  associates and friends of Mr. Standyk and Mr. Cox. These funds were
for general  operating  expenses.  At the time these funds were raised they were
not intended for the Praxis Pharmaceuticals licensing agreement. In this regard,
we  issued  3,000,000  shares  for  $150,000  on March  15,  1999 and we  issued
1,000,000  shares on April 1, 1999 for $300,000.  The proceeds are to be used to
implement our new plan of business.  At the time of sale,  the proceeds were not
earmarked for the Praxis Pharmaceuticals licensing agreement.

Since we have entered into an agreement with Praxis Pharmaceuticals for research
and development, we will encounter significant research and development expenses
over  the  next  twelve  months.   In  addition  to  the  terms  of  the  Praxis
Pharmaceuticals   agreement,   we  may  seek  to  conduct  other   research  and
development,  which  would  result in  expenses  beyond  those  outlined  in the
agreement with Praxis Pharmaceuticals.

Our goal is to have Praxis  Pharmaceuticals  provide us with  products  that are
ready  for  market.  The  first  product  that we hope to  receive  from  Praxis
Pharmaceuticals  is the  anti-wrinkle  compound while the second is an arthritis
product.

Since we outsource most of our operations, we do not anticipate establishing our
own  manufacturing  facilities  over the next  twelve  months.  Beyond this time
frame,  we plan to make a decision  with regard to purchase or sale of any plant
and significant  equipment in the long term after products are introduced to the
public through our website, if ever.

As conditions  dictate, we will engage additional  employees.  We do not plan to
make any  significant  changes in the number of  employees  over the next twelve
months.

PART II- OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS
None.

ITEM 2. CHANGES IN SECURITIES AND USE OF PROCEEDS
None.

Item 3. Defaults Upon Senior Securities
None.

Item 4. Submission of Matters to a Vote of Security Holders
None.

Item 5. Other Information
None.

Item 6. Exhibits and Reports on Form 8-K
None.

SIGNATURES

In accordance with the requirements of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned, thereunto duly authorized.


Dated:  11/16/00                       By:  /s/  Byron  Cox
                                           ----------------
                                           Byron Cox, President and Director